The best is the enemy of the good: Time for a biopsy-sparing approach for Helicobacter pylori diagnosis and treatment in children in the COVID-19 era?

Monzani, Alice; Lionetti, Paolo; Rabbone, Ivana; Lionetti, Elena

Monzani, Alice; Lionetti, Paolo; Rabbone, Ivana; Lionetti, Elena.

Monzani A; Division of Pediatrics, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Lionetti P; Gastroenterology and Nutrition Unit, Department of Neurology, Pharmacology, Psychology and Child Health (NEUROFARBA), Meyer Children's Hospital, University of Florence, Florence, Italy.
Rabbone I; Division of Pediatrics, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Lionetti E; Department of Pediatrics, Marche Polytechnic University, Ancona, Italy.

Helicobacter ; 26(4): e12826, 2021 Aug.

Article in English | MEDLINE | ID: covidwho-1247180

Subject(s)

COVID-19; Helicobacter Infections; Biopsy; Child; Helicobacter Infections/diagnosis; Helicobacter Infections/drug therapy; Helicobacter pylori; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Helicobacter Infections / COVID-19 Type of study: Diagnostic study Limits: Child / Humans Language: English Journal: Helicobacter Journal subject: Bacteriology Year: 2021 Document Type: Article Affiliation country: Hel.12826

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google